Michael Ellenbogen, a director at Evolv Technologies Holdings, sold 80,745 shares of Class A Common Stock on May 15, 2026, for a total of $454,594.
The shares were sold in multiple transactions at prices ranging from $5.53 to $5.77 each, under a Rule 10b5-1 trading plan adopted on June 12, 2025.
Currently, the stock trades at $5.62, down ~18% over the past week, with a market cap of $1.01 billion.
Prior to the sale, Ellenbogen acquired the shares by exercising stock options at $0.24 per share, totaling $19,378. The options vested 25% on January 31, 2018, and in 36 equal monthly installments thereafter.
After the transactions, Ellenbogen directly holds 2,083,961 shares. He also indirectly holds 151,135 shares through the Family Horizon Trust and retains 1,058,504 stock options.
According to Bond.az analysis, EVLV appears overvalued relative to its Fair Value. The platform offers 6 additional ProTips for EVLV and comprehensive Pro Research Reports covering 1,400+ US equities.
In other news, Evolv Technologies reported Q1 2026 revenue of $46.3 million, beating estimates of $38.46 million. EPS was -$0.03. TD Cowen reiterated a Buy rating with a $10.00 price target.
